SR ONE CAPITAL MANAGEMENT, LP - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
SR ONE CAPITAL MANAGEMENT, LP ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,402,483
-62.5%
6,526,4760.0%7.89%
-55.5%
Q2 2023$41,116,799
+9.2%
6,526,4760.0%17.73%
+26.4%
Q1 2023$37,657,767
-43.8%
6,526,4760.0%14.03%
-42.6%
Q4 2022$66,961,644
-28.8%
6,526,476
+16.0%
24.44%
-43.2%
Q3 2022$94,075,000
+19.4%
5,626,4760.0%43.01%
+11.6%
Q2 2022$78,771,000
-13.3%
5,626,4760.0%38.55%
-17.1%
Q1 2022$90,868,000
-24.6%
5,626,4760.0%46.52%
-31.7%
Q4 2021$120,463,0005,626,47668.08%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders